BioCryst Pharmaceuticals (NasdaqGS:BCRX) FY Conference January 12, 2026 01:30 PM ET Company ParticipantsBabar Ghias - CFOBill Sheridan - Chief Development OfficerCharlie Gayer - CEOConference Call ParticipantsNone - AnalystJess Fye - AnalystJess FyeGreat. Welcome. Good morning, everyone. My name's Jess Fye. I'm a biotech analyst at JPMorgan. We're so glad to have you here at the 44th Annual JPMorgan Healthcare Conference. We're continuing the conference with BioCryst. And first, you're going to hear a prese ...